Table 3.

Metavir fibrosis stage of HCC patients without liver cirrhosis (only patients with available detailed trichrome stain data; n = 212)

Liver disease, n(%)	F0	F1	F2	F3
Cryptogenic (n = 71)	43 (60.6)	8 (11.3)	12 (16.9)	8 (11.3)
NAFLD (n = 58)	23 (39.7)	17 (29.3)	7 (12.0)	11 (19.0)
Hepatitis C (n = 48)	3 (6.3)	3 (6.3)	19 (39.6)	23 (47.9)
Hepatitis B (n = 18)	2 (11.1)	4 (22.2)	7 (38.9)	5 (27.8)
Alcoholic liver disease (n = 12)	1 (8.3)	5 (41.7)	2 (16.7)	4 (33.3)
Hereditary hemochromatosis (n = 5)	0	1 (20)	2 (40)	2 (40)

NAFLD nonalcoholic fatty liver disease